Recalled prescription and over-the-counter drugs, supplements and their FDA classification.
Hikma Pharmaceuticals recalls 10mg Ramipril capsules due to failed impurities test. Products may contain dicyclohexylurea (DCU) which could cause harm. Check NDC codes 76282-673-01 or 76282-673-05 for affected lots.
Apotex recalls 37.5mg Paxil CR tablets due to failing 24-month stability tests. This may affect medication safety. Check your prescription bottle for NDC 60505-4379-3.
B. Braun Medical recalls Lactated Ringer's Injection USP 1000mL (L7500) due to particulate matter. Affected units have specific lot numbers and expiration dates. Consumers should contact the manufacturer for details.
Fresenius Kabi recalls Tyenne (tocilizumab-aazg) injection due to glass particles found in some batches. This may cause serious injury if injected. Affected units have specific lot numbers and expiration dates.
Church & Dwight recalls Zicam Cold Remedy nasal swabs due to microbiological testing failures found during FDA inspection. Affected lots have specific expiration dates and UPC codes.
Golden State Medical Supply recalls 200mg carbamazepine tablets with black specks due to CGMP deviations. Patients should contact their doctor for guidance.
Accord Healthcare recalls 1000-count levothyroxine tablets with subpotent drug levels. These tablets may not provide proper thyroid hormone treatment. Consumers should contact the manufacturer for details.
Accord Healthcare recalls 1000-count levothyroxine tablets due to subpotent drug levels. This may not provide proper thyroid hormone treatment. Consumers should contact the manufacturer for details.
Accord Healthcare recalls specific levothyroxine sodium tablets (100 mcg) with subpotent drug content. These tablets may not provide the intended thyroid hormone levels, potentially causing health issues if used without medical supervision.
Accord Healthcare recalls 90-count and 1000-count Levothyroxine Sodium Tablets (175 mcg) due to subpotent drug content. This may not provide proper thyroid hormone levels. Consumers should contact the manufacturer for details.
Accord Healthcare recalls 1000-count levothyroxine tablets with subpotent drug risk. Affected lots expire 09/30/2026. Consumers should contact pharmacy for guidance.
Mallinckrodt recalls Acthar Gel 5mL vials due to glass and stopper particles. Patients should contact their doctor for alternative treatment options.
Accord Healthcare recalls 1000-count levothyroxine tablets due to subpotent drug content. This may not provide proper thyroid hormone levels. Consumers should contact their doctor for alternative treatment options.
Accord Healthcare recalls 90-count Levothyroxine tablets (300 mcg) due to subpotent drug content. This may result in insufficient thyroid hormone levels. Consumers should contact the manufacturer for details.
Accord Healthcare recalls 90-count and 1000-count levothyroxine tablets with subpotent drug levels. These tablets may not provide the correct dosage, risking health issues. Return or contact for details.
Accord Healthcare recalls 1000-count levothyroxine tablets due to subpotent drug content. This may cause insufficient thyroid hormone levels. Affected products have specific lot numbers and expiration dates.
Accord Healthcare recalls 1000-count levothyroxine tablets due to subpotent drug levels. This may not provide proper thyroid hormone treatment. Consumers should contact the manufacturer for details.
Accord Healthcare recalls 1000-count levothyroxine tablets with subpotent drug risk. Affected lots expire by 2026. Stop using if you have these specific batches.
Accord Healthcare recalls 90-count and 1000-count levothyroxine tablets with subpotent drug levels. These tablets may not provide the intended thyroid hormone dose. Consumers should contact the manufacturer for details.
Zydus Pharmaceuticals recalls 25mg Mirabegron Extended-Release Tablets due to N-Nitroso impurity found in some batches. This may pose a risk to health. Affected products have specific lot numbers and expiration dates.
Fresenius Kabi recalls Morphine Sulfate Injection syringes that may be labeled incorrectly with Dilaudid instead of Morphine. This could lead to incorrect medication use. Consumers should check labels and contact the company for details.
Novartis recalls Diovan 160mg tablets (NDC 0078-0359-34) manufactured by Patheon in Greenville, NC with lot AV5913C. Failed dissolution specifications may affect drug effectiveness.
Sun Pharmaceutical recalls 200mg Carbamazepine tablets with black spots caused by burnt excipients during manufacturing. Rx-only medication distributed by Taro Pharmaceuticals USA. No remedy specified in official notice.
Lupin Pharmaceuticals recalls 0.05% Clobetasol Propionate Cream due to failed content uniformity. This may affect medication strength. Check NDC 68180-956-04 and lot numbers for affected products.
Shoolin Pharma Chem LLP recalls 1kg Tadalafil USP bags due to FDA inspection finding CGMP deviations. This prescription-only compound must be handled with care.
Shoolin Pharma Chem recalls 1.00kg sildenafil tablets due to FDA inspection finding CGMP deviations. This prescription-only compound may pose quality risks. Consumers should contact the manufacturer for details.
Shoolin Pharma Chem recalls 500g Tadalafil (Rx only) due to FDA inspection finding CGMP deviations. Affected batches may pose quality risks. Consumers should contact the manufacturer for details.
Shoolin Pharma Chem LLP recalls Tadalafil 100g bags due to FDA inspection finding CGMP deviations. Affected products have specific lot and expiry dates. Consumers should contact the manufacturer for details.
Shoolin Pharma Chem recalls sildenafil tablets due to FDA inspection finding CGMP deviations. This prescription-only product was manufactured for compounding. No specific remedy is stated in the recall notice.
Liebel-Flarsheim recalls Optiray Imaging Bulk Package-350 (Ioversol 74%) due to potential particulate matter in the injection solution. This could cause blockages or reactions if injected. Affected units have NDC 0019-1333-65 and lot # 25ZF3670.
Heritage Pharmaceuticals recalls clindamycin oral solution (75 mg/5 mL) due to foreign particles in reconstituted bottles. This medication is prescription-only and distributed by Avet.
Shilpa Medicare recalls PEMRYDI RTU (pemetrexed injection) due to green discoloration in vials. This may indicate contamination. Check vial color before use.
Shilpa Medicare recalls PEMRYDI RTU (pemetrexed injection) vials with green discoloration. This may indicate contamination and should be discarded to avoid potential health risks.
Apollo Care recalls SEMAGLUTIDE 5mg vials due to potential particulate matter that could cause injection site reactions. Affected vials have specific NDC and lot numbers.
Apollo Care recalls SEMAGLUTIDE 4.5mg vials due to potential particulate matter. This could cause injection site reactions. Check NDC 71170-812-03 with specific lots for affected products.
Apollo Care recalls SEMAGLUTIDE 9mg vials due to particulate matter that could cause injection site reactions. Affected vials have specific NDC and lot numbers. Consumers should contact Apollo Care for details.
Apollo Care recalls SEMAGLUTIDE 10mg vials due to particulate matter that could cause injection site reactions. Affected vials have NDC 71170-722-02 and lot AC-017274, expiring Dec 2026.
Apollo Care recalls 20mg SEMAGLUTIDE vials due to nylon/polyamide and silk/proteinaceous particulate matter that could cause injection site reactions. Affected vials have specific NDC and lot numbers.
Prestige Brands Holdings recalls CLEAR EYES Maximum Itchy Eye Relief drops due to potential contamination. Affected lots may not be sterile, risking eye infections. Consumers should check NDC 67172-999-01 and lot numbers.
Apollo Care recalls 0.9mg SEMAGLUTIDE vials due to nylon/polyamide and silk/proteinaceous particulate matter that could cause injection site reactions.
Apollo Care recalls SEMAGLUTIDE 6.75mg vials due to particulate matter that could cause injection site reactions. Affected vials have specific lot numbers and expiration dates.
Apollo Care recalls SEMAGLUTIDE 2.5mg vials due to nylon/polyamide and silk/proteinaceous particulate matter that could cause injection site reactions.
Apollo Care recalls SEMAGLUTIDE 2.25MG vials due to particulate matter risk. Affected lots expire 11/24/2026 or 12/31/2026. Stop using if you have these vials.
Apollo Care recalls SEMAGLUTIDE 12.5MG vials due to nylon/polyamide and proteinaceous particulate matter that could cause injection site reactions.
Apollo Care recalls SEMAGLUTIDE 7.5mg vials due to nylon/polyamide and silk/proteinaceous particulate matter that could cause injection site reactions.
Regeneron recalls Libtayo (cemiplimab-rwlc) injections due to lack of sterility assurance. This could lead to infections if used improperly. Affected units have specific lot numbers and expiration dates.
American Regent recalls Tralement (trace elements injection) vials due to contamination with hair, glass, and paraformaldehyde. Stop using if you have these specific vial numbers.
Baxter Healthcare recalls Cefazolin injection bags with particulate matter. Affected units contain lot # LD175708, expiring Feb 2027. Consumers should contact Baxter for details.
American Regent recalls cyanocobalamin injections with particulate matter (hair, glass, paraformaldehyde) that could cause serious injury if injected.
American Regent recalls Selenious Acid Injection (12 mcg/2mL) due to contamination with hair, glass, and paraformaldehyde. This poses a risk of serious injury if injected. Affected units have specific NDC numbers and expiration dates.
American Regent recalls aminocaproic acid injection due to contamination with hair, glass, and paraformaldehyde. This poses a risk of serious injury during IV infusion. Consumers should contact the manufacturer for details.
American Regent recalls niCARd: 25 mg/10mL injection vials contaminated with hair, glass, or paraformaldehyde. Product may cause serious injury if injected. Contact for return instructions.
Mylan recalls 333mg Acamprosate Calcium tablets due to failed dissolution specifications. This may affect medication effectiveness. Contact Mylan for details.
American Regent recalls nitroglycerin injections contaminated with hair, glass, or paraformaldehyde. Stop using affected lots before expiration.
American Regent recalls Atropine Sulfate injection (1 mg/mL IV) due to contamination with hair, glass, and paraformaldehyde. This poses a risk of serious injury if injected. Affected lots: 24353 (expiring 9/30/2026).
American Regent recalls 10% acetylcysteine solution vials due to contamination with hair, glass, and paraformaldehyde. Stop using if you have these vials.
American Regent recalls Papaverine HCl injection vials due to glass and paraformaldehyde contamination. This poses a risk of serious injury if injected. Consumers should contact the manufacturer for details.
American Regent recalls ACETYLCYSTEINE SOLUTION, USP 20% (200 mg/mL) vials due to contamination with hair, glass, and paraformaldehyde. Stop using immediately if you have these vials.
American Regent recalls Multrys (Trace Elements Injection 4, USP) vials due to hair, glass and paraformaldehyde contamination. Affected lots expire 4/30/2027. Contact for return instructions.
American Regent recalls cyanocobalamin injections with particulate matter (hair, glass, paraformaldehyde) that could cause serious injury if injected. Stop using and contact for replacement.
